Challenges in the management of infantile factor H associated hemolytic uremic syndrome

被引:36
作者
Filler, G
Radhakrishnan, S
Strain, L
Hill, A
Knoll, G
Goodship, TH
机构
[1] Univ Ottawa, Ottawa Hosp, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[2] Univ Ottawa, Ottawa Hosp, Dept Surg, Ottawa, ON, Canada
[3] Univ Ottawa, Ottawa Hosp, Dept Med, Ottawa, ON, Canada
[4] Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
atypical hemolytic uremic syndrome; plasma exchange; factor H; HF-1; gene;
D O I
10.1007/s00467-004-1526-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We describe a 1-year old with four episodes of recurrent hemolytic uremic syndrome (HUS). Family history suggested an autosomal dominant mode of inheritance. Factor H concentrations in the blood were normal in the affected family members. Mutation screening in the human complement factor H gene (HF-1) revealed a novel mutation in exon 23 (c.3546_3581dup36). The HF-1 gene encodes complement factor H and the mutation leads to the insertion of 12 additional amino acids after codon 1176 in factor H. The recurrent HUS responded to plasma infusions and renal function improved from a glomerular filtration rate of 21 to 50 ml/min per 1.73 m(2). The infusions of fresh-frozen plasma were necessary at once-weekly intervals at a dose of 40-45 ml/kg in order to maintain remission and resulted in significant hyperproteinemia. This was addressed by intermittent plasma exchange through an arterio-venous fistula. The prognosis and therapeutic dilemmas are discussed.
引用
收藏
页码:908 / 911
页数:4
相关论文
共 19 条
[1]   The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical, and epidemiologic findings [J].
Banatvala, N ;
Griffin, PM ;
Greene, KD ;
Barrett, TJ ;
Bibb, WF ;
Green, JH ;
Wells, JG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) :1063-1070
[2]   High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome [J].
Coppo, P ;
Bussel, A ;
Charrier, S ;
Adrie, C ;
Galicier, L ;
Boulanger, E ;
Veyradier, A ;
Leblanc, T ;
Alberti, C ;
Azoulay, E ;
Le Gall, JR ;
Schlemmer, B .
MEDICINE, 2003, 82 (01) :27-38
[3]   PROLONGATION OF ACUTE RENAL-FAILURE IN 2 PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME DUE TO EXCESSIVE PLASMA INFUSION THERAPY [J].
EDDY, AA ;
GEARY, DF ;
BALFE, JW ;
CLARK, WF ;
BAUMAL, R .
PEDIATRIC NEPHROLOGY, 1989, 3 (04) :420-423
[4]   Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? [J].
Filler, G ;
Lepage, N .
PEDIATRIC NEPHROLOGY, 2003, 18 (10) :981-985
[5]  
FITZPATRICK MM, 1993, J PEDIATR-US, V122, P532
[6]   Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality [J].
Gerber, A ;
Kirchhoff-Moradpour, AH ;
Obieglo, S ;
Brandis, M ;
Kirschfink, M ;
Zipfel, PF ;
Goodship, JA ;
Zimmerhackl, LB .
PEDIATRIC NEPHROLOGY, 2003, 18 (09) :952-955
[7]   PLASMA-EXCHANGE IN CHILDREN WITH HEMOLYTIC-UREMIC SYNDROME AT RISK OF POOR OUTCOME [J].
GIANVITI, A ;
PERNA, A ;
CARINGELLA, A ;
EDEFONTI, A ;
PENZA, R ;
REMUZZI, G ;
RIZZONI, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (02) :264-266
[8]   The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children [J].
Loirat, C ;
Niaudet, P .
PEDIATRIC NEPHROLOGY, 2003, 18 (11) :1095-1101
[9]   Plasmapheresis - Technical aspects and indications [J].
Madore, F .
CRITICAL CARE CLINICS, 2002, 18 (02) :375-+
[10]   Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome [J].
Manuelian, T ;
Hellwage, J ;
Meri, S ;
Caprioli, J ;
Noris, M ;
Heinen, S ;
Jozsi, M ;
Neumann, HPH ;
Remuzzi, G ;
Zipfel, PF .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08) :1181-1190